חזרה לתוצאות החיפוש

Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Kidney Diseases · Kidney Diseases, Chronic · Urological Diseases · Glomerulonephritis · Glomerular Disease · Glomerulonephritis, IGA · Glomerulopathy · Immunoglobulin Disease

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Colorado Kidney Care Nephrology, Denver, Colorado, United States

    Contact: Principal Investigator (Laura Kooienga)

  • Nephrology Associates Of Central FL, Orlando, Florida, United States

    Contact: Principal Investigator (Arvind Madan)

  • NY Nephrology, Clifton Park, New York, United States

    Study coordinator · +1 518 579 0017
    Contact: Principal Investigator (Frank Cortazar)

  • Icahn School of Medicine at Mount Sinai, New York, New York, United States

    Contact: Principal Investigator (Kristin Meliambro)

  • Knoxville Kidney Center Pllc, Brentwood, Tennessee, United States

    Contact: Principal Investigator (George Newman)

  • Dallas Renal Group, Dallas, Texas, United States

    Contact: Principal Investigator (Phuong Truong)

  • Dallas Renal Group, Dallas, Texas, United States

    Study coordinator · +1 214 697 7187
    Contact: Principal Investigator (Irfan Agha)

  • Nephro Asso North Illinois Indiana, Houston, Texas, United States

    Contact: Principal Investigator (Suneel Udani)

  • Novartis Investigative Site, Caba, Buenos Aires, Argentina

  • Novartis Investigative Site, La Plata, Buenos Aires, Argentina

  • Novartis Investigative Site, Buenos Aires, Buenos Aires F.D., Argentina

  • Novartis Investigative Site, Catamarca, Catamarca Province, Argentina

  • Novartis Investigative Site, Santa Fe, Argentina

  • Novartis Investigative Site, Kogarah, New South Wales, Australia

  • Novartis Investigative Site, Toronto, Ontario, Canada

  • Novartis Investigative Site, Kuantan, Pahang, Malaysia

  • Novartis Investigative Site, Kuala Lumpur, Malaysia

  • Novartis Investigative Site, Cheonan, Chungcheongnam-do, South Korea

  • Novartis Investigative Site, Guri-si, Gyeonggi-do, South Korea

  • Novartis Investigative Site, Seongnam-si, Gyeonggi-do, South Korea

  • Novartis Investigative Site, Seoul, Seoul, South Korea

מובילי המחקר

  • Novartis Pharmaceuticals

    Study Director

    Novartis Pharmaceuticals

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)